Quantitative LC-MS/MS analysis of arachidonoyl amino acids in mouse brain with treatment of FAAH inhibitor
Quantitative LC-MS/MS analysis of arachidonoyl amino acids in mouse brain with treatment of FAAH inhibitor
复制标题
DOI:
10.1016/j.ab.2012.09.031
复制
发表时间:
2013-01-15
影响因子:
2.9
通讯作者:
Barker, Eric
中科院分区:
文献类型:
--
作者:
Han, Bingnan;Wright, Rachel;Barker, Eric
An additional class of endogenous lipid amides, N-arachidonoyl amino acids (Ara-AAs), is growing in significance in the field of endocannabinoids. The development, validation, and application of a sensitive and selective method to simultaneously monitor and quantify the level of Ara-AAs along with anandamide (AEA) and 2-arachidonoyl glycerol (2-AG) in mouse brain has been established. The linearity of the method over the concentration ranges of 0.2-120 pg/mu l for the standards of N-arachidonoyl amino acids. N-arachidonoyl alanine (NAAla), serine (NASer), gamma-aminobutyric acid (NAGABA), and glycine (NAGly); 0.7-90 pg/mu l for AEA-d(0)/d(8); and 7.5-950 pg/mu l for 2-AG was determined with R-2 values of 0.99. Also the effects of the FAAH inhibitor URB 597 on the endogenous levels of these analytes were investigated. AEA and NASer brain levels exhibit a dose-dependent increase after systemic administration of URB 597, whereas NAGly and NAGABA were significantly decreased after treatment. NAAla and 2-AG were not altered after URB 597 treatment. The potential benefit of establishing this assay extends beyond the quantification of the Ara-AAs along with AEA and 2-AG in mouse brain, to reveal a variety of pharmacological effects and physiological roles of these analytes. (c) 2012 Elsevier Inc. All rights reserved.